about
Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibilityGranzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout miceA Comprehensive and System Review for the Pharmacological Mechanism of Action of Rhein, an Active Anthraquinone IngredientTrends and advances in tumor immunology and lung cancer immunotherapyImmunotherapeutic targeting of membrane Hsp70-expressing tumors using recombinant human granzyme BGranzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis.EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines.Inflammatory cell distribution in primary merkel cell carcinoma.Human and mouse granzyme M display divergent and species-specific substrate specificities.Granzyme h serum levels variations with both reproductive hormone receptors, and related hormone receptors in breast cancer patients.Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon.Destructive impact of T-lymphocytes, NK and Mast cells on basal cell layers: implications for tumor invasion.Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients.Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.Global expression profiling of peripheral Qa-1-restricted CD8αα+TCRαβ+ regulatory T cells reveals innate-like features: implications for immune-regulatory repertoireNatural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentiaChronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in ratsGranzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo.Granzyme B-expressing neutrophils correlate with bacterial load in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques.Mechanistic Study of the Phytocompound, 2- β -D-Glucopyranosyloxy-1-hydroxytrideca-5,7,9,11-tetrayne in Human T-Cell Acute Lymphocytic Leukemia Cells by Using Combined Differential Proteomics and Bioinformatics Approaches.ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease.Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.Can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?Altered circadian expression of cytokines and cytolytic factors in splenic natural killer cells of Per1(-/-) mutant mice.Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?Impact of brief exercise on peripheral blood NK cell gene and microRNA expression in young adults.X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity.Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.The multifaceted role of autophagy in tumor evasion from immune surveillanceTumor control by human cytomegalovirus in a murine model of hepatocellular carcinomaAiming to immune elimination of ovarian cancer stem cellsGenomic and functional analysis of the host response to acute simian varicella infection in the lung.Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials.The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growth.Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia.Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents.
P2860
Q21184029-0C7FE879-44D2-4B82-A8F4-2A5684208123Q24625080-169E5191-1AD0-4A4A-A58C-6C64188CF4E9Q27023870-344DB560-CEFC-4121-8ECF-0C717DDA5AEFQ28067674-32A2162F-22ED-4301-90CB-DDDBC9F67C9EQ28729023-34B9F81F-5E31-443D-BD2B-6891B0AE63ABQ30571557-B6BA51B8-D578-4AF5-A046-E04F3660F4B4Q31115054-6058B3F1-0A23-49A1-93BA-BE32B47D8371Q33784707-84373DDD-E726-4874-A0AC-55CE279571D6Q33820294-BD2626F9-B29A-425B-8ADF-280C75DF3276Q33896439-9B891A45-9CF6-4E30-B69C-50E5EA107BC1Q34082508-9007F813-FDEC-4EC9-8DA8-FB0FFDF346A9Q34518059-2356722C-FD39-43B7-8C17-296642A20530Q34738446-36064FF3-3969-46A8-BD3F-5723D35AAF4BQ34955529-062CEC30-1C3A-4B5E-8A43-951C4358F8ADQ34985704-93684171-B73C-4F21-98ED-02BB60119C2BQ35049821-C7D45F36-AFBE-4ABE-85AB-4284704229B3Q35680851-40E30D80-2156-46C2-89A5-DBC82C13C1D4Q35743162-18DAE6C3-D9BB-4E43-99C0-CB9EA4330455Q35803377-3ADA9D6A-CEB1-44E5-B28D-16235C160E82Q36023188-70B2A8E2-1466-4784-9E0A-E44CB28847D5Q36062297-E27BAC7C-A200-4990-A7AE-0B05E0C08A1AQ36236245-EA48BEEE-82B4-4312-8FA5-90A2B507D275Q36424657-C022E350-7D17-4F67-97E0-D0E98E2CB4BCQ36587186-56123C4F-7091-45A1-B931-B34F2CD65558Q36605526-29748955-E63E-40D1-9D8E-982C6EE143CDQ36679671-BD42EEFC-4C6E-4F40-A725-481ADDDFF2EDQ36713394-CE3CAF76-B865-4F6C-8947-6B9A7C86F629Q36737701-6D920E8C-393B-4493-BA72-27C752ECADA3Q36751784-6AF7FD17-979E-446F-89EE-10DFD5D94636Q36823719-7B1BA819-4CB9-4B9A-A5D7-559695DD47BBQ37109549-5A5BEBF2-1454-48B7-A5FC-D578CCE8424DQ37225207-913E3C1B-3C44-4155-B52E-3A3BE9D3A920Q37266548-BFD3D489-B1AD-45B3-844C-AF78F301EFD3Q37291473-B1902788-70D3-41AA-A50D-23D99919D1BDQ37489634-2C027FDE-196B-4C34-A91C-2E4D3FE82616Q37512173-BA23C5BB-F979-436F-BA13-5931B72A9957Q37577621-95487778-0F70-49FE-894E-D1EB273EFE0DQ37597931-AE889755-1B4E-48CB-BF34-5B8C93E27BD4Q37624221-9F4D235C-597F-4CB2-8B36-D22C49F247F8Q37737964-B23D5896-2510-4085-9145-D9B515EF8BE6
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Granzymes in cancer and immunity.
@ast
Granzymes in cancer and immunity.
@en
Granzymes in cancer and immunity.
@nl
type
label
Granzymes in cancer and immunity.
@ast
Granzymes in cancer and immunity.
@en
Granzymes in cancer and immunity.
@nl
prefLabel
Granzymes in cancer and immunity.
@ast
Granzymes in cancer and immunity.
@en
Granzymes in cancer and immunity.
@nl
P2093
P356
P1476
Granzymes in cancer and immunity.
@en
P2093
P2888
P304
P356
10.1038/CDD.2009.206
P577
2010-01-15T00:00:00Z
P5875
P6179
1050017831